BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 820170)

  • 1. Glycoprotein catabolism in brain tissue in the lysosomal enzyme deficiency diseases.
    Brunngraber EG; Davis LG; Javaid JI; Berra B
    Adv Exp Med Biol; 1976; 68():31-48. PubMed ID: 820170
    [No Abstract]   [Full Text] [Related]  

  • 2. The biochemistry of sphingolipid storage diseases.
    Sandhoff K
    Angew Chem Int Ed Engl; 1977 May; 16(5):273-85. PubMed ID: 406814
    [No Abstract]   [Full Text] [Related]  

  • 3. Gangliosides, glycoproteins, and glycosaminoglycans in Krabbe's disease.
    Berra B; Brunngraber EG; Aguilar V; Aro A; Zambotti V
    Clin Chim Acta; 1973 Aug; 47(2):325-8. PubMed ID: 4271153
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain glycoproteins in GM1-gangliosidosis: isolation and carbohydrate composition of glycopeptides.
    Brunngraber EG; Berra B; Zambotti V
    FEBS Lett; 1973 Aug; 34(2):350-2. PubMed ID: 4747848
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic disorders of lysosomes.
    Hirschhorn R; Weissmann G
    Prog Med Genet; 1976; 1():49-101. PubMed ID: 180565
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and biochemical pathophysiology of ataxia in the sphingolipidoses.
    Philippart M
    Adv Neurol; 1978; 21():131-49. PubMed ID: 104554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hereditary diseases related to a disorder in the breakdown of carbohydrate-containing compounds].
    Vidershaĭn GIa
    Usp Sovrem Biol; 1974; 77(3):434-51. PubMed ID: 4278594
    [No Abstract]   [Full Text] [Related]  

  • 8. Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.
    Inui K; Wenger DA
    J Clin Invest; 1983 Nov; 72(5):1622-8. PubMed ID: 6415115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathological changes in brain glycoproteins.
    Berra B; Brunngraber EG
    Biochem Exp Biol; 1977; 13(1):31-9. PubMed ID: 26363
    [No Abstract]   [Full Text] [Related]  

  • 10. Disorders of lipid metabolism.
    Brady RO
    Biochem Soc Symp; 1972; (35):113-27. PubMed ID: 4217183
    [No Abstract]   [Full Text] [Related]  

  • 11. Glycoproteins in brain tissue of the O-variant of GM2 gangliosidosis.
    Brunngraber EG; Brown BD; Aro A
    J Neurochem; 1974 Jan; 22(1):125-8. PubMed ID: 4818864
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism of cerebroside sulphate and subcellular distribution of its metabolites in cultured skin fibroblasts derived from controls, metachromatic leukodystrophy, globoid cell leukodystrophy and Farber disease.
    Inui K; Furukawa M; Nishimoto J; Okada S; Yabuuchi H
    J Inherit Metab Dis; 1987; 10(3):293-6. PubMed ID: 3123795
    [No Abstract]   [Full Text] [Related]  

  • 13. Basic findings and current developments in sphingolipidoses.
    Pilz H; Heipertz R; Seidel D
    Hum Genet; 1979 Mar; 47(2):113-34. PubMed ID: 108196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in investigations of sphingolipidoses.
    Adachi M; Schneck L; Volk BW
    Acta Neuropathol; 1978 Aug; 43(1-2):1-18. PubMed ID: 97916
    [No Abstract]   [Full Text] [Related]  

  • 15. Binding of concanavalin A to the brain-specific proteins obtained from human white matter by affinity chromatography.
    Bruungraber EG; Susz JP; Javaid J; Aro A; Warecka K
    J Neurochem; 1975 Apr; 24(4):805-6. PubMed ID: 804537
    [No Abstract]   [Full Text] [Related]  

  • 16. The cerebral lipidoses.
    Malone MJ
    Pediatr Clin North Am; 1976 May; 23(2):303-26. PubMed ID: 818606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composition of sialoglycans isolated from Gaucher's spleen.
    Friedman RB; Kanfer JN
    Biochem Med; 1974 Apr; 9(4):327-33. PubMed ID: 4832200
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparation and properties of concanavalin A-binding glycopeptides derived from rat brain glycoproteins.
    Javaid JI; Hof H; Brunngraber EG
    Biochim Biophys Acta; 1975 Sep; 404(1):74-82. PubMed ID: 1182017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingolipidoses: molecular manifestations and biochemical strategies.
    Pentchev PG; Barranger JA
    J Lipid Res; 1978 May; 19(4):401-9. PubMed ID: 96198
    [No Abstract]   [Full Text] [Related]  

  • 20. Inherited lipid storage diseases of the central nervous system.
    Percy AK; Shapiro LJ; Kaback MM
    Curr Probl Pediatr; 1979 Sep; 9(11):1-51. PubMed ID: 117977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.